Patrick Jeffrey Marshall

Patrick Jeffrey Marshall discloses dealings in Edesa Biotech, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 23 May 2023 to 27 May 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 1 June 2026: a share grant, in Edesa Biotech, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.